1.Analysis of influencing factors of depression in AIDS hemodialysis patients
Zhangqing ZHOU ; Gongzhen CUI ; Xuefen WANG ; Jian LIU ; Fangyan XU ; Huili LI
China Modern Doctor 2024;62(36):56-59
Objective To explore the status quo of depression and medical-social support in human immunodeficiency virus(HIV)/acquired immunodeficiency syndrome(AIDS)hemodialysis patients,as well as the effect of medical-social support on depression.Methods A total of 80 HIV/AIDS hemodialysis patients from Xixi Hospital in Hangzhou from March 2022 to March 2024 were collected.Center for epidemiological survey-depression scale(CES-D)and medical social support scale(MOS-SSS)were used to assess patients for depression and medical social support.Structural equation model was used to analyze relationship between medical social support and depression.Results 42 of the 80 subjects(52.5%)had depressive symptoms(CES-D score≥16 points).The results of univariate analysis showed that health status,antiviral treatment status,medical social support had an impact on HIV depression(P<0.05).Simple linear regression showed that health status(95%CI:-9.901--2.635)and antiviral treatment status(95%CI:-12.969--3.394)were the influencing factors for depression(P<0.05).The total score of medical social support,tangible support dimension,information and emotional support dimension,positive social interaction dimension,emotional support dimension were associated with depression(P<0.001).Multiple linear regression analysis showed that medical social support was negatively associated with depression.The higher medical social support was the lower incidence of depression.Conclusion The prevalence of depression in AIDS hemodialysis patients is high,and medical social support has a positive effect on alleviating their condition.
2.Analysis of influencing factors of depression in AIDS hemodialysis patients
Zhangqing ZHOU ; Gongzhen CUI ; Xuefen WANG ; Jian LIU ; Fangyan XU ; Huili LI
China Modern Doctor 2024;62(36):56-59
Objective To explore the status quo of depression and medical-social support in human immunodeficiency virus(HIV)/acquired immunodeficiency syndrome(AIDS)hemodialysis patients,as well as the effect of medical-social support on depression.Methods A total of 80 HIV/AIDS hemodialysis patients from Xixi Hospital in Hangzhou from March 2022 to March 2024 were collected.Center for epidemiological survey-depression scale(CES-D)and medical social support scale(MOS-SSS)were used to assess patients for depression and medical social support.Structural equation model was used to analyze relationship between medical social support and depression.Results 42 of the 80 subjects(52.5%)had depressive symptoms(CES-D score≥16 points).The results of univariate analysis showed that health status,antiviral treatment status,medical social support had an impact on HIV depression(P<0.05).Simple linear regression showed that health status(95%CI:-9.901--2.635)and antiviral treatment status(95%CI:-12.969--3.394)were the influencing factors for depression(P<0.05).The total score of medical social support,tangible support dimension,information and emotional support dimension,positive social interaction dimension,emotional support dimension were associated with depression(P<0.001).Multiple linear regression analysis showed that medical social support was negatively associated with depression.The higher medical social support was the lower incidence of depression.Conclusion The prevalence of depression in AIDS hemodialysis patients is high,and medical social support has a positive effect on alleviating their condition.
3.Incidence and risk factors of renal injury in human immunodeficiency virus infection/acquired immunodeficiency syndrome patients with poor immune reconstitution
Danyan YU ; Xumin YING ; Huili LI ; Zhangqing ZHOU ; Xiaofeng ZHENG ; Dingyan YAN ; Zongxing YANG ; Wenhui ZHANG ; Guoxiang ZHENG ; Zhongdong ZHANG ; Jianhua YU
Chinese Journal of Infectious Diseases 2023;41(8):502-506
Objective:To investigate the incidence and risk factors of renal injury in human immunodeficiency virus (HIV) infection/acquired immunodeficiency syndrome (AIDS) patients with poor immune reconstitution.Methods:The HIV infection/AIDS patients with poor immune reconstitution who were visited Second Department of Infection of Hangzhou Xixi Hospital from January to December 2021 were enrolled. The clinical data and laboratory examinations of the patients were collected, and the relevant risk factors were analyzed by logistic regression.Results:Among 303 HIV infection/AIDS patients with poor immune reconstitution, 59(19.5%) patients had renal injury. Logistic regression analysis showed that hypertension (odds ratio ( OR)=0.200, 95% confidence interval (95% CI) 0.065 to 0.618, P=0.005), taking tenofovir ( OR=0.275, 95% CI 0.130 to 0.580, P=0.001), hypoproteinemia ( OR=1.045, 95% CI 1.006 to 1.086, P=0.022), and low CD4 + T lymphocytes level ( OR=1.009, 95% CI 1.003 to 1.014, P=0.001) were risk factors for renal injury. Conclusions:The incidence of renal injury in HIV infection/AIDS patients with poor immune reconstitution is high. Hypertension, taking tenofovir, hypoproteinemia, and low CD4 + T lymphocytes level are risk factors for renal injury in patients.
4.Mechanism of Bushen Huatan Prescription in Regulation of Osteogenesis and Adipogenic Differentiation and Improvement of Postmenopausal Bone Loss in Ovariectomized Rats with Osteoporosis
Yan ZHANG ; Nan XIANG ; Guangwen ZHOU ; Zhangqing LI ; Zhangkui TAN ; Shiyi HUANG ; Mengxin XIONG ; Lin ZHANG
Chinese Journal of Experimental Traditional Medical Formulae 2022;28(20):53-60
ObjectiveTo explore the underlying mechanism of Bushen Huatan prescription in alleviating postmenopausal osteoporosis (PMOP) by maintaining the balance of osteogenesis and adipogenic differentiation in ovariectomized rats with osteoporosis. MethodSeventy-five 6-month-old non-pregnant female SD rats were randomly divided into sham-operation group, model group, atorvastatin group, liviol group, and Bushen Huatan prescription group. Bilateral ovaries were removed in the four groups except the sham-operation group, while only the same mass of adipose tissue around the ovaries was removed in the sham-operation group. On the 5th week after surgery, drugs were consecutively administrated for 8 weeks. Rats in the Bushen Huatan prescription group received 9.4 mg·kg-1 of the prescription, rats in the atorvastatin group received 0.92 mg·kg-1 of atorvastatin, rats in the Liviol group received 0.23 mg·kg-1 of liviol, and rats in the model group and the sham-operation group received saline once a day. Micro-computed tomography (Micro CT) was used to detect bone mineral density (BMD) of rat tibia in each group. Hematoxylin-eosin (HE) staining was used to detect the relative area of rat bone marrow adipose tissue (BMAT) in each group. Real-time fluorescence quantitative polymerase chain reaction (Real-time PCR) and Western blot were used to detect the relative expression levels of Runt-related transcription factor 2 (Runx2), peroxisome proliferator-activated receptor (PPARγ), leptin (LPN), and leptin receptor (OBR) in bone tissues. ResultAs compared with the sham operation group, the BMD of rats in the model group decreased (P<0.05), while the relative area of BMAT increased (P<0.05). In addition, the expression levels of LPN, OBR, and Runx2 decreased in the model group (P<0.05), while the level of PPARγ increased (P<0.05). As compared with the model group, the BMD of rats in the atorvastatin group, the Livial group, and the Bushen Huatan prescription group increased (P<0.05), and the relative area of BMAT decreased (P<0.05). The expression levels of LPN, OBR, and Runx2 in these groups increased (P<0.05), while the expression level of PPARγ decreased (P<0.05). ConclusionBushen Huatan prescription plays the anti-osteoporosis role in the rat model of PMOP through up-regulating LPN and OBR in bone tissues and maintaining the balance of osteogenesis and adipogenic differentiation, thereby reducing postmenopausal bone loss and playing a role in the prevention and treatment of PMOP.
5.An interpretation of Adult Strabismus Preferred Practice Pattern
Chinese Journal of Experimental Ophthalmology 2020;38(6):527-532
The American Academy of Ophthalmology (AAO) published the Adult Strabismus Preferred Practice Pattern(PPP) in September 2019.The PPP provides an authoritative guidance for the clinical diagnosis and treatment of adult strabismus based on the best clinical evidence.This PPP of version 2019 incorporates recent advances in the field of adult strabismus into the guide, and comprehensively describes and updates the definition, epidemiology, classification, diagnosis and treatment of adult strabismus.This article introduces and interprets the main content of the guide.

Result Analysis
Print
Save
E-mail